NCT02976233

Brief Summary

Over the last two decades, non-invasive ventilation (NIV) has been widely reported as an effective method to avoid the need of endotracheal intubation (ETI) and improve survival in the acute care setting. Given the risks associated with either premature NIV discontinuation or delays in NIV interruption, evaluating readiness to weaning from NIV is a critical challenge in patients with Acute Respiratory Failure (ARF). Up to date, bedside measurements used to predict NIV outcomes are extremely limited. NIV weaning as well as decision of ETI are mainly supported by clinical and physiologic parameters. More sophisticated techniques used to predict weaning outcome during spontaneous breathing trials have never achieved a bedside broad-spectrum use due to their invasiveness, the inconsistent results in demonstrating reproducible outcomes, the requirements of additional trainee personnel and complicated equipment, and the difficult application in awake and non-intubated patients. Recently, ultrasound has been used for the rapid assessment of diaphragm function in acutely ill patients. The advantages of the ultrasound in detecting diaphragm dysfunction as compared with other techniques are the less invasiveness, the avoidance of radiation hazards and the bedside feasibility. Direct imaging of changes in diaphragm thickening (DT) during spontaneous breathing may provide the assessment of both the muscle and the respiratory pump functioning. Indeed, DT has been correlated with the diaphragm strength and the muscle shortening. The volume of diaphragm muscle mass remains constant while it contracts. Consequently, as the muscle shortens it thickens itself and measurements of changes in such a thickening (DT) are inversely related to changes in diaphragm length. Studies in patients with diaphragm paralysis have confirmed the absence of DT. Moreover, since the diaphragm is the major muscle of inspiration, the presence of diaphragm shortening and contraction may predict successful extubation in patients who are invasively ventilated. The aim of the present study is to assess whether DT as measured by ultrasound may predict NIV outcome in patients with de-novo ARF admitted to the Emergency Department (ED).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

October 23, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 29, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

November 29, 2016

Status Verified

November 1, 2016

Enrollment Period

1 year

First QC Date

October 23, 2016

Last Update Submit

November 24, 2016

Conditions

Keywords

Acute Respiratory FailureNon Invasive VentilationUltrasoundDiaphragm Thickening

Outcome Measures

Primary Outcomes (1)

  • Ultrasound Diaphragmayic Thickening to predict NIV outcome in patients with de-novo ARF

    Diaphragm thicknening (DT) will be measured using a 7-10 MHz linear ultrasound probe set to B mode (Vividier, General Electrics). Both the right and left diaphragm will be imaged at the apposition point of the diaphragm and the rib cage on the midaxillary line, between the 8th and the 10th intercostal spaces. DT will be measured at either the end-expiration or the end-inspiration. The percent change in DT between end-expiration and end-inspiration (ΔDT%) will be calculated as \[(DTend-inspiration-DTend-expiration/DTend-expiration)×100\]. The ΔDT% for each patient will represent the mean of three to five breaths. Measurements will be performed by 2 different and appropriately trained operators who are routinely involved in the management of the patients

    96 hours

Secondary Outcomes (1)

  • Duration of Mechanical Ventilation (MV) and Emergency Department (ED) stay as well as hospital outcome.

    96 hours for the duration of MV and the ED stay+ 1 year for hospital outcome

Study Arms (1)

Acute Respiratory Failure in NIV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients with de-novo ARF requiring NIV treatment while they will be admitted to the Emergency Department at Gemelli's Hospital, Rome-Italy.

You may qualify if:

  • Respiratory rate \> 35 breaths/min,
  • PaO2/FiO2 \< 200 while the patient is breathing oxygen through a Venturi mask and active contraction of the accessory muscles of respiration or paradoxical abdominal motion.

You may not qualify if:

  • Age \< 18 years,
  • Pregnancy,
  • Diaphragm paralysis,
  • Neuromuscular disorders,
  • Palliative NIV in patients with malignancy,
  • Ineffective cough,
  • Inability to protect airways.
  • BMI \> 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensive Care Unit Policlinico A. Gemelli

Rome, Italy, 00168, Italy

RECRUITING

Related Publications (1)

  • Mercurio G, D'Arrigo S, Moroni R, Grieco DL, Menga LS, Romano A, Annetta MG, Bocci MG, Eleuteri D, Bello G, Montini L, Pennisi MA, Conti G, Antonelli M. Diaphragm thickening fraction predicts noninvasive ventilation outcome: a preliminary physiological study. Crit Care. 2021 Jun 26;25(1):219. doi: 10.1186/s13054-021-03638-x.

Study Officials

  • Giovanna Mercurio, MD

    Fondazione Policlinico Agostino Gemelli Rome, Department of Anesthesia and Intensive Care Unit

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Temistocle Taccheri, MD

CONTACT

Simone Carelli, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD of Department of Anesthesia and Intensive Care , Policlinico A. Gemelli , Catholic University of the Sacred Heart in Rome

Study Record Dates

First Submitted

October 23, 2016

First Posted

November 29, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2017

Study Completion

October 1, 2018

Last Updated

November 29, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations